Stifel slashes price target on Genesis Healthcare Inc. [GEN] – find out why.

Genesis Healthcare Inc. [NYSE: GEN] stock went on an upward path that rose over 13.33% on Wednesday, amounting to a one-week price increase of more than 39.85%. The company report on January 5, 2021 that Genesis HealthCare Announces Leadership Change.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

George V. Hager, Jr. Retires as CEO and DirectorBoard of Directors Appoints Current Chairman, Robert H. Fish as New CEO.

Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, announced that George V. Hager, Jr. has decided to retire as the Company’s Chief Executive Officer (CEO) and Director. Genesis’ Board of Directors has appointed the Company’s current Chairman of the Board, Robert (“Bob”) H. Fish as CEO, effective, January 5, 2021. Bob will remain Chairman of the Board.

Over the last 12 months, GEN stock dropped by -49.34%. The average equity rating for GEN stock is currently 3.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $125.51 million, with 113.15 million shares outstanding and 63.80 million shares in the current float. Compared to the average trading volume of 1.63M shares, GEN stock reached a trading volume of 8239449 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Genesis Healthcare Inc. [GEN]:

Stifel have made an estimate for Genesis Healthcare Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 29, 2018. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $3 to $3.50. The new note on the price target was released on November 21, 2016, representing the official price target for Genesis Healthcare Inc. stock. Previously, the target price had yet another drop from $5 to $3, while RBC Capital Mkts kept a Outperform rating on GEN stock.

The Average True Range (ATR) for Genesis Healthcare Inc. is set at 0.05, with the Price to Sales ratio for GEN stock in the period of the last 12 months amounting to 0.03. Price to Free Cash Flow for GEN in the course of the last twelve months was 0.63 with Quick ratio for the last quarter at 0.90.

GEN Stock Performance Analysis:

Genesis Healthcare Inc. [GEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 39.85. With this latest performance, GEN shares gained by 34.71% in over the last four-week period, additionally plugging by 2.38% over the last 6 months – not to mention a drop of -49.34% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GEN stock in for the last two-week period is set at 75.42, with the RSI for the last a single of trading hit 80.98, and the three-weeks RSI is set at 71.30 for Genesis Healthcare Inc. [GEN]. The present Moving Average for the last 50 days of trading for this stock 0.5242, while it was recorded at 0.6462 for the last single week of trading, and 0.6734 for the last 200 days.

Insight into Genesis Healthcare Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Genesis Healthcare Inc. [GEN] shares currently have an operating margin of +1.12 and a Gross Margin at +4.29. Genesis Healthcare Inc.’s Net Margin is presently recorded at +0.32.

Return on Total Capital for GEN is now 1.64, given the latest momentum, and Return on Invested Capital for the company is 0.43. Additionally, GEN Total Debt to Total Capital is recorded at 120.47, with Total Debt to Total Assets ending up at 88.70.

Reflecting on the efficiency of the workforce at the company, Genesis Healthcare Inc. [GEN] managed to generate an average of $266 per employee. Receivables Turnover for the company is 7.67 with a Total Asset Turnover recorded at a value of 0.95.Genesis Healthcare Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.90 and a Current Ratio set at 0.90.

GEN Stock EPS

With the latest financial reports released by the company, Genesis Healthcare Inc. posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 9.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Genesis Healthcare Inc. go to 10.00%.

Genesis Healthcare Inc. [GEN] Insider Position Details

There are presently around $18 million, or 22.80% of GEN stock, in the hands of institutional investors. The top three institutional holders of GEN stocks are: VANGUARD GROUP INC with ownership of 4,736,667, which is approximately -12.913% of the company’s market cap and around 0.30% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 3,824,346 shares of the stock with an approximate value of $2.93 million in GEN stocks shares; and FIRST WASHINGTON CORP, currently with $2.33 million in GEN stock with ownership of nearly 0% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Genesis Healthcare Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 14 institutional holders increased their position in Genesis Healthcare Inc. [NYSE:GEN] by around 742,677 shares. Additionally, 37 investors decreased positions by around 3,843,535 shares, while 18 investors held positions by with 18,510,612 shares. The mentioned changes placed institutional holdings at 23,096,824 shares, according to the latest SEC report filing. GEN stock had 11 new institutional investments in for a total of 318,122 shares, while 14 institutional investors sold positions of 937,707 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam